Literature DB >> 16838105

ENA Actimineral Resource A restores bone loss and bone quality in ovariectomized rats.

Sun Hee Do1, Sung-Yong Hwa, Won-Il Jeong, Ji-Won Lee, Hyun-Jung Kim, In-Seon Lee, Kyu-Shik Jeong.   

Abstract

The purpose of this study was to examine the effects of ENA Actimineral Resource A (ENA-A), seaweed origin alkaline water, on postmenopausal osteoporosis in ovariectomized (OVX) rats. The 12-week old Wistar rats were divided randomly into 4 groups: ovariectomized (OVX), OVX plus 0.5% ENA-A, OVX plus 5% ENA-A and OVX plus 10% ENA-A. A histopathological analysis indicated that ENA-A could prevent OVX-induced bone loss by increasing femur trabecular bone area in a dose-dependent manner. ENA-A significantly (p<0.05) increased serum estradiol levels, decreased serum osteocalcin activity and suppressed serum pyridinoline (PYD) levels. The in vitro effects of ENA-A were also studied using MC3T3-E1 cells. ENA-A significantly stimulated cell proliferation and increased both ALP activity and calcium deposition in a dose-dependent manner. These results suggest that the treatment of ovariectomized rats with ENA-A not only prevents bone resorption but also appears to maintain the cancellous bone structure of postmenopausal osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838105     DOI: 10.1007/s11010-006-9269-5

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Stimulation of osteoblast proliferation by the cartilage-derived growth promoting factors chondromodulin-I and -II.

Authors:  Y Mori; Y Hiraki; C Shukunami; S Kakudo; M Shiokawa; M Kagoshima; H Mano; Y Hakeda; T Kurokawa; F Suzuki; M Kumegawa
Journal:  FEBS Lett       Date:  1997-04-14       Impact factor: 4.124

2.  Early changes in biochemical markers of bone turnover are associated with long-term changes in bone mineral density in elderly women on alendronate, hormone replacement therapy, or combination therapy: a three-year, double-blind, placebo-controlled, randomized clinical trial.

Authors:  Susan L Greenspan; Neil M Resnick; Robert A Parker
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

3.  On the history and mechanism of alizarin and alizarin red S stains for calcium.

Authors:  H Puchtler; S N Meloan; M S Terry
Journal:  J Histochem Cytochem       Date:  1969-02       Impact factor: 2.479

4.  Pathogenesis of osteoporosis.

Authors:  D W Dempster; R Lindsay
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

5.  Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.

Authors:  P A Price; M K Williamson; J W Lothringer
Journal:  J Biol Chem       Date:  1981-12-25       Impact factor: 5.157

6.  Menopausal changes in bone remodeling.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

7.  Quantification of metaphyseal modeling in children treated with bisphosphonates.

Authors:  Kate Ward; Christopher T Cowell; David G Little
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

8.  The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: correlation to histomorphometric indices of turnover.

Authors:  Babul Borah; Erik L Ritman; Thomas E Dufresne; Steven M Jorgensen; Sheng Liu; Jarek Sacha; Roger J Phipps; Russell T Turner
Journal:  Bone       Date:  2005-07       Impact factor: 4.398

9.  Changes in serum receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and interleukin-6 levels in patients with glucocorticoid-induced osteoporosis treated with human parathyroid hormone (1-34).

Authors:  Eric C Buxton; Wei Yao; Nancy E Lane
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

10.  Sex steroids and bone mass. A study of changes about the time of menopause.

Authors:  C Slemenda; S L Hui; C Longcope; C C Johnston
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

View more
  2 in total

1.  The protective effect of ENA Actimineral resource A on CCl4-induced liver injury in rats.

Authors:  Il-Hwa Hong; Hoon Ji; Sung-Yong Hwa; Won-Il Jeong; Da-Hee Jeong; Sun-Hee Do; Ji-Min Kim; Mi-Ran Ki; Jin-Kyu Park; Moon-Jung Goo; Ok-Kyung Hwang; Kyung-Sook Hong; Jung-Youn Han; Hae-Young Chung; Kyu-Shik Jeong
Journal:  Mar Biotechnol (NY)       Date:  2010-10-05       Impact factor: 3.619

2.  ENA-A actimineral resource A extends lifespan associated with antioxidant mechanism in SMP30 knockout mice.

Authors:  Jung-Youn Han; Meeyul Hwang; Sung-Yong Hwa; Jin-Kyu Park; Mi-Ran Ki; Il-Hwa Hong; Ah-Young Kim; Eun-Mi Lee; Eun-Joo Lee; Chang-Woo Min; Kyung-Ku Kang; Myeong-Mi Lee; Soo-Eun Sung; Kyu-Shik Jeong
Journal:  Mol Cell Biochem       Date:  2014-03-07       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.